ABIRATERON-ACETAT-FORMULIERUNG

European patent · EP3578266 · Deleted

Register entry

Publication number
EP3578266
Application number
EP19173089
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 17, 2014
Published
Dec 11, 2019
Granted
Jun 19, 2024
Deleted
Oct 24, 2025
Reason
Annual fee unpaid
IPC classes
A61P 5/28 (2006.01)
A61P 5/44 (2006.01)
A61P 43/00 (2006.01)
A61K 9/14 (2006.01)
A61K 9/20 (2006.01)
A61K 31/58 (2006.01)
C07J 43/00 (2006.01)
A61K 9/16 (2006.01)
A61P 13/08 (2006.01)
A61P 35/00 (2006.01)
A61K 31/573 (2006.01)
Priority
US 201361789141 P 15.03.2013
US 201361883941 P 27.09.2013
Divided from
EP14765788
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 24, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.10.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.10.2025

  2. Apr 30, 2025

    Change

    Published in Swissreg on 30.04.2025

  3. Jun 19, 2024

    Granted

    Published in Swissreg on 19.06.2024

Parties

Holder

Sun Pharmaceutical Industries Limited

Sun House Plot No. 201 B/1 Western Express Highway Goregaon (E), Mumbai Maharashtra 400 063, IN

Inventor

Callahan, Matt

Haverford, PA Pennsylvania 19041, US

Nemeth, Paul

Philadelphia, PA Pennsylvania 19112, US

Bosch, William, H.

Philadelphia, PA Pennsylvania 19112, US

Norret, Marck

Hovea, 6071, West Australia (WA), AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.